Erasca, Inc. Common Stock vs. Johnson & Johnson
Erasca, Inc. Common Stock and Johnson & Johnson are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ERAS | JNJ | |
|---|---|---|
| Market Cap | $5.41 billion | $618.09 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| ERAS | JNJ | |
|---|---|---|
| Dividend Yield | — | 2.05% |
ERAS and JNJ split the dividend factors evenly.
Risk & Sentiment
| ERAS | JNJ | |
|---|---|---|
| Short Interest | 0.25% | 0.67% |
ERAS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ERAS overview, ERAS financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.